Literature DB >> 29257905

The Prevalence and Symptom Profile of Asthma-COPD Overlap: The HUNT Study.

Anne H Henriksen1,2, Arnulf Langhammer3, Sigurd Steinshamn1,2, Xiao-Mei Mai3, Ben M Brumpton1,4.   

Abstract

The concept of asthma and COPD as separate conditions has been questioned, and the term asthma-COPD overlap syndrome has been introduced. We assessed the prevalence, symptoms, and lifestyle factors of asthma-COPD overlap (ACO) in a large Norwegian population-based study. From 2006 to 2008, a total of 50,777 residents of Nord-Trøndelag participated in the Nord-Trøndelag Health Study, Norway. They completed questionnaires regarding respiratory symptoms, disease status, and medication use. We estimated the prevalence and 95% confidence intervals of ACO. Additionally, spirometry was used to estimate the prevalence of ACO in a subgroup. The prevalence of self-reported ACO was 1.9%, and in age groups <40, 40-60 and ≥60 years it was 0.7%, 1.4%, and 3.2%, respectively. Among those reporting COPD, the proportion of ACO was 0.56. In the spirometry subgroup when ACO was defined as doctor diagnosed asthma ever and FEV1/FVC < 0.70, the prevalence of ACO was 2.0%. All respiratory symptoms, separately or in combination, as well as medication use were reported most frequently in those with ACO compared to the other groups. Strikingly, we observed a two-fold higher proportion of allergic rhinitis in ACO compared to COPD only. In this Norwegian population, the prevalence of self-reported ACO was 1.9%, and the corresponding proportion of ACO among those with COPD was 0.56. Participants with ACO generally had the highest proportions of respiratory symptoms compared to asthma or COPD.

Entities:  

Keywords:  ACOS; epidemiology; obstructive lung disease; spirometry

Mesh:

Year:  2017        PMID: 29257905     DOI: 10.1080/15412555.2017.1408580

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  8 in total

1.  Asthma, asthma control and risk of acute myocardial infarction: HUNT study.

Authors:  Aivaras Cepelis; Ben M Brumpton; Lars E Laugsand; Håvard Dalen; Arnulf Langhammer; Imre Janszky; Linn B Strand
Journal:  Eur J Epidemiol       Date:  2019-09-11       Impact factor: 8.082

2.  Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries.

Authors:  Brooks W Morgan; Matthew R Grigsby; Trishul Siddharthan; Muhammad Chowdhury; Adolfo Rubinstein; Laura Gutierrez; Vilma Irazola; J Jaime Miranda; Antonio Bernabe-Ortiz; Dewan Alam; Robert A Wise; William Checkley
Journal:  J Allergy Clin Immunol       Date:  2018-10-04       Impact factor: 10.793

3.  A burning need to redefine airways disease: Biomass smoke exposure identified as a unique risk factor for asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries.

Authors:  Amir A Zeki; Cameron H Flayer; Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2018-12-05       Impact factor: 10.793

4.  Clinical ACO phenotypes: Description of a heterogeneous entity.

Authors:  S Lainez; I Court-Fortune; P Vercherin; L Falchero; T Didi; P Beynel; D Piperno; E Frappe; M Froudarakis; J M Vergnon; G Devouassoux
Journal:  Respir Med Case Rep       Date:  2019-08-27

5.  Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis.

Authors:  Mostafa Hosseini; Amir Almasi-Hashiani; Mahdi Sepidarkish; Saman Maroufizadeh
Journal:  Respir Res       Date:  2019-10-23

6.  Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma.

Authors:  Ane Aamli Gagnat; Miriam Gjerdevik; Stein Atle Lie; Amund Gulsvik; Per Bakke; Rune Nielsen
Journal:  Eur Clin Respir J       Date:  2020-08-07

7.  Genetic Associations and Architecture of Asthma-COPD Overlap.

Authors:  Catherine John; Anna L Guyatt; Nick Shrine; Richard Packer; Thorunn A Olafsdottir; Jiangyuan Liu; Lystra P Hayden; Su H Chu; Jukka T Koskela; Jian'an Luan; Xingnan Li; Natalie Terzikhan; Hanfei Xu; Traci M Bartz; Hans Petersen; Shuguang Leng; Steven A Belinsky; Aivaras Cepelis; Ana I Hernández Cordero; Ma'en Obeidat; Gudmar Thorleifsson; Deborah A Meyers; Eugene R Bleecker; Lori C Sakoda; Carlos Iribarren; Yohannes Tesfaigzi; Sina A Gharib; Josée Dupuis; Guy Brusselle; Lies Lahousse; Victor E Ortega; Ingileif Jonsdottir; Don D Sin; Yohan Bossé; Maarten van den Berge; David Nickle; Jennifer K Quint; Ian Sayers; Ian P Hall; Claudia Langenberg; Samuli Ripatti; Tarja Laitinen; Ann C Wu; Jessica Lasky-Su; Per Bakke; Amund Gulsvik; Craig P Hersh; Caroline Hayward; Arnulf Langhammer; Ben Brumpton; Kari Stefansson; Michael H Cho; Louise V Wain; Martin D Tobin
Journal:  Chest       Date:  2022-01-31       Impact factor: 10.262

8.  [Lung sounds can be used as an indicator for assessing severity of chronic obstructive pulmonary disease at the initial diagnosis].

Authors:  Shifeng Chen; Minyu Huang; Xianru Peng; Yafei Yuan; Shuyu Huang; Yanmei Ye; Wenqu Zhao; Bohou Li; Huishan Han; Shuluan Yang; Shaoxi Cai; Haijin Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-02-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.